Tribunal orders reconsideration for duty segregation in pharmaceuticals appeal

The Tribunal remanded the case back to the Original Authority for reconsideration, emphasizing the need to segregate dutiable PP medicines from exempted generic medicines to determine the correct duty liability. The Commissioner's failure to address this segregation led to the appeal being disposed of by remand for further examination and appropriate orders. The Tribunal directed the Original Authority to verify records and allow the appellant to present their case, highlighting the importance of correlating destruction, export, and clearances with dutiable or exempted medicines.

---

---

Issues:
Manufacture of medicines falling under Chapter 30 of the Schedule to the Central Excise Tariff Act, 1985; Exemption benefit availed; Demand of Central Excise duty; Allegations of clandestine clearance; Duty liability on generic and PP medicines; Segregation of dutiable PP medicines from exempted generic medicines; Shortage of excisable items; Destruction and export of medicines; Duty liability on unaccounted/clandestinely cleared PP medicines; Appeal against the order of the Commissioner.

Analysis:
The appellants, engaged in manufacturing medicines falling under Chapter 30 of the Schedule to the Central Excise Tariff Act, 1985, appealed against the Commissioner's order confirming a demand of Rs. 7,81,799 and imposing an equal penalty while dropping the demand of Central Excise duty of Rs. 23,01,680. The case originated from a show cause notice issued in 1999 alleging clandestine clearance of goods under the cover of parallel invoices without duty payment. The Commissioner's order-in-original was dated 07/12/01, which was appealed and remanded for fresh consideration by the CESTAT. The current impugned order resulted from these remand proceedings.

The appellant contested the order, arguing that the invoices relied upon were proforma and covered generic medicaments with nil Central Excise duty chargeable at that time. They claimed no segregation was made between PP medicines and generic medicaments. Regarding shortages of excisable items, the appellant explained that some final product quantities did not meet standards and were destroyed as per Drug Control Rules, with duty paid and entered in returns. They also mentioned exporting medicines without proper entries and argued that duty liability on PP medicines should not arise due to turnover not exceeding Rs. 30 lakhs.

During the appeal, the appellant presented a comparison chart on shortages of Ampoules and Vials, emphasizing that segregation between generic and PP medicines was crucial to determine duty liability correctly. The Authorized Representative reiterated the findings of the impugned order, emphasizing duty demand on unaccounted/clandestinely cleared PP medicines, even if turnover was below Rs. 30 lakhs.

After hearing both sides and examining the records, the Tribunal noted the Commissioner's failure to discuss the dutiablity of generic and PP medicines in the impugned order. The Tribunal emphasized the necessity to segregate dutiable PP medicines from exempted generic medicines to determine the correct duty liability for goods cleared under parallel invoices. They highlighted the importance of correlating destruction, export, and clearances with dutiable or exempted medicines, directing the Original Authority to verify records and reconsider the matter, providing the appellant an opportunity to present their case. Consequently, the appeal was disposed of by way of remand for further consideration and appropriate orders.

---